COMMUNIQUÉ DE PRESSE publié le 18/01/2024 à 13:00, il y a 1 année 10 mois Envision Pharma Group Welcomes Industry Veteran and HR Expert Carolyn Bartholdson as Chief People Officer Envision Pharma Group appoints Carolyn Bartholdson as its new Chief People Officer and member of the Executive Leadership Team. With her extensive experience in the life sciences industry, Carolyn is set to play a crucial role in securing and retaining top talent to support Envision's growth. Her strategic vision aligns seamlessly with the company's priorities, and her exceptional leadership experience will be integral to advancing Envision's strategic goals. Envision Pharma Group Talent Acquisition Life Sciences Industry Carolyn Bartholdson Chief People Officer
COMMUNIQUÉ DE PRESSE publié le 16/01/2024 à 13:00, il y a 1 année 10 mois Envision Pharma Group Appoints Life Sciences Industry Veteran Alice Choi as President, Integrated Medical Capabilities and Solutions (IMC) Envision Pharma Group (Envision) has appointed Alice Choi as President, Integrated Medical Capabilities and Solutions (IMC) to lead the organization's IMC division of experts in medical strategy, medical communications, publications planning and delivery, and patient engagement, delivering smarter, faster outcomes for life sciences clients. With a wealth of experience in the global life sciences industry, Alice brings strategic expertise, knowledge, and insight to drive the company's vision forward and meet client needs. She joins from IPG Health, where she served as EVP, Managing Director, Client Solutions, APAC, and played a pivotal role in business growth and operational excellence. Her commitment to best practices and standards in medical communications is evident in her various leadership roles. Envision Pharma Group, founded in 2001, is a leading global technology-enabled strategic solutions partner for the life sciences industry, working with over 200 pharma and biotech companies. Learn more at www.envisionpharmagroup.com. Envision Pharma Group Alice Choi Medical Communications Life Sciences Clients Global Technology-enabled Strategic Solutions
COMMUNIQUÉ DE PRESSE publié le 15/11/2023 à 13:00, il y a 2 années Envision Pharma Group Announces New AI Innovation Board and Appoints Chairwoman
COMMUNIQUÉ DE PRESSE publié le 15/06/2023 à 13:00, il y a 2 années 5 mois OKRA.ai, an Envision Pharma Group Company, Appoints Dr. Yahya Anvar to Senior Leadership Position
COMMUNIQUÉ DE PRESSE publié le 09/05/2023 à 13:00, il y a 2 années 6 mois Envision Pharma Group Announces Appointment of Dr. Deepti Sodhi Jaggi to Board of Directors
COMMUNIQUÉ DE PRESSE publié le 04/05/2023 à 13:00, il y a 2 années 7 mois Envision Pharma Group Appoints Healthcare Industry Expert and Experienced Leader Dr. Jennifer Costello, PharmD, BCPS, CMPP, as Chief Medical Officer
COMMUNIQUÉ DE PRESSE publié le 03/05/2023 à 15:05, il y a 2 années 7 mois Envision Pharma Group Appoints Mike Glover to Senior Vice President, Payer and HTA Solutions to Drive Acceleration and Expansion in Value & Access and Data Analytics
COMMUNIQUÉ DE PRESSE publié le 01/05/2023 à 13:00, il y a 2 années 7 mois Envision Pharma Group Appoints Industry Leader Tino Quintero as General Manager/VP of Market Access & Customer Insights
COMMUNIQUÉ DE PRESSE publié le 30/03/2023 à 13:00, il y a 2 années 8 mois Envision Pharma Group Appoints Richard Gorman as President, Strategic Consulting
COMMUNIQUÉ DE PRESSE publié le 29/03/2023 à 17:45, il y a 2 années 8 mois Envision Pharma Group Appoints Life Science Industry Expert James Streeter as New President of Technology, CTO
Publié le 05/12/2025 à 17:18, il y a 3 heures 46 minutes La vidéo de la réunion de présentation des résultats 2024-2025 du 5 décembre 2025 est disponible
Publié le 05/12/2025 à 17:18, il y a 3 heures 46 minutes The video of the 2024-2025 results presentation meeting on December 5, 2025, is available
Publié le 05/12/2025 à 15:10, il y a 5 heures 53 minutes Mersen: Number of shares and voting rights as of November 30, 2025
Publié le 05/12/2025 à 15:10, il y a 5 heures 53 minutes Mersen : nombre d'actions et de droits de vote au 30 novembre 2025
Publié le 05/12/2025 à 13:58, il y a 7 heures 6 minutes RELATIF A LA MISE A DISPOSITION DU PUBLIC DE LA NOTE D'INFORMATION ET DES INFORMATIONS RELATIVES AUX CARACTERISTIQUES, NOTAMMENT JURIDIQUES, FINANCIERES ET COMPTABLES DE LEGRAND FRANCE
Publié le 05/12/2025 à 20:25, il y a 39 minutes The Feedback Loop: Why SMX's Adoption in One Industry Accelerates Interest in All the Others
Publié le 05/12/2025 à 20:15, il y a 49 minutes When Proof Becomes Infrastructure, Markets Rewrite the Story (NASDAQ: SMX)
Publié le 05/12/2025 à 19:50, il y a 1 heure 14 minutes Gold, Rare Earth Minerals, Digital Assets: The Market Just Realized SMX Sits in All Three
Publié le 05/12/2025 à 19:20, il y a 1 heure 44 minutes The Multi-Sector Validation Shock: Why SMX Became Impossible for Markets to Ignore
Publié le 05/12/2025 à 18:45, il y a 2 heures 19 minutes Four Global Markets, One Engine: SMX Just Redefined What a Supply Chain Can Prove
Publié le 05/12/2025 à 18:58, il y a 2 heures 6 minutes EQS-Adhoc: HORNBACH Holding AG & Co. KGaA: Reduced earnings in Q3 2025/26 – Guidance for adjusted EBIT at previous year’s level still valid
Publié le 05/12/2025 à 18:15, il y a 2 heures 49 minutes Completion of merger to form Helvetia Baloise Holding Ltd
Publié le 05/12/2025 à 17:46, il y a 3 heures 18 minutes Booster Precision Components Holding GmbH announces the successful completion of its Written Procedure to amend and waive certain terms under the terms and conditions of the Bonds